| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/12/2005 | WO2005042781A2 Methods for producing a paired tag from a nucleic acid sequence and methods of use thereof |
| 05/12/2005 | WO2005042780A1 Phage antibodies to radiation-inducible neoantigens |
| 05/12/2005 | WO2005042778A1 Using nucleic acids for clinical microbiology testing |
| 05/12/2005 | WO2005042776A1 Method of determining predisposition towards atherosclerosis |
| 05/12/2005 | WO2005042775A1 Short biological polymers on solid supports |
| 05/12/2005 | WO2005042773A1 Methods and compositions for identifying therapeutic compounds |
| 05/12/2005 | WO2005042772A1 Methods and compositions for identifying therapeutic compounds |
| 05/12/2005 | WO2005042771A2 Colorimetric substrates, colorimetric sensors, and methods of use |
| 05/12/2005 | WO2005042770A2 Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria |
| 05/12/2005 | WO2005042769A1 Methods for inducing complete apoptosis of liver cells expressing hbx protein and screening for substances or genes that inhibit the apoptosis |
| 05/12/2005 | WO2005042767A2 Compositions and methods for detecting severe acute respiratory syndrome coronavirus |
| 05/12/2005 | WO2005042764A2 Primers, methods and kits for amplifying or detecting human leukocyte antigen alleles |
| 05/12/2005 | WO2005042763A2 Optimization of gene expression analysis using immobilized capture probes |
| 05/12/2005 | WO2005042762A2 Lrpap1 genetic markers associated with galantamine response |
| 05/12/2005 | WO2005042760A2 Systems and methods for detecting biological features |
| 05/12/2005 | WO2005042759A2 Expression profiling using microarrays |
| 05/12/2005 | WO2005042746A1 Bacterial virulence factors and uses thereof |
| 05/12/2005 | WO2005042734A1 Ser/thr kinase involved in autophagocytosis as a target for fungicides |
| 05/12/2005 | WO2005042733A1 Hbv variants detection and application |
| 05/12/2005 | WO2005042725A2 Liver cancer biomarkers |
| 05/12/2005 | WO2005042716A2 Nucleic acid binding oligonucleotides |
| 05/12/2005 | WO2005042715A2 Angiogensis models using nestin-expressing stem cells to image nascent blood vessels |
| 05/12/2005 | WO2005042713A2 Quantitative multiplex methylation-specific pcr |
| 05/12/2005 | WO2005042709A2 Compositions, methods and detection technologies for reiterative oligonucleotide synthesis |
| 05/12/2005 | WO2005042706A2 Ephx2 genetic markers associated with galantamine response |
| 05/12/2005 | WO2005042704A2 Differential enzymatic fragmentation |
| 05/12/2005 | WO2005042701A2 Methods to identify compounds useful for tumor sensitization to dna damage |
| 05/12/2005 | WO2005042695A2 Lipoparticles comprising proteins, methods of making, and using the same |
| 05/12/2005 | WO2005042578A2 Antibody fab fragment specific for breast cancer |
| 05/12/2005 | WO2005042576A1 Clq RELATED PROTEIN |
| 05/12/2005 | WO2005042574A1 High troughput functional assay for g-protein coupled receptors using a rap-ras chimeric protein |
| 05/12/2005 | WO2005042570A1 Hcv ns3-ns4a protease resistance mutants |
| 05/12/2005 | WO2005042552A2 Modulation of sglt2 expression |
| 05/12/2005 | WO2005042504A1 Fluorinated resorufin compounds and their application in detecting hydrogen peroxide |
| 05/12/2005 | WO2005042146A2 Apparatus and method for dispensing fluid, semi-solid and solid samples |
| 05/12/2005 | WO2005042002A2 Treatment of rhematoid arthritis with flip antagonists |
| 05/12/2005 | WO2005041903A2 Methods and reagents for diagnosis and treatment of diabetes |
| 05/12/2005 | WO2005041896A2 Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke |
| 05/12/2005 | WO2005041880A2 RhPV AS A MODEL FOR HPV-INDUCED CANCERS |
| 05/12/2005 | WO2005041750A2 Method for identifying compounds that affect expression of tryptophan hydroxylase isoform 2 |
| 05/12/2005 | WO2005026192A3 Hpv cd8+ t-cell epitopes |
| 05/12/2005 | WO2005024418A3 Novel markers for alternatively activated macrophages |
| 05/12/2005 | WO2005022143A3 Method and apparatus for assay of electrochemical properties |
| 05/12/2005 | WO2005021777A3 Uses of spatial configuration to modulate protein function |
| 05/12/2005 | WO2005021731A3 Soluble analyte detection and amplification |
| 05/12/2005 | WO2005019249A8 Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases |
| 05/12/2005 | WO2005007883A3 Method for detecting and/or identifying bacteria of genus staphylococcus |
| 05/12/2005 | WO2005005662A3 Secreted proteins as markers for cell differentiation |
| 05/12/2005 | WO2005005596A3 Characterization of the earliest stages of the severe acute respiratory syndrome (sars) virus and uses thereof |
| 05/12/2005 | WO2005003766A3 Methods of regulating metabolism and mitochondrial function |
| 05/12/2005 | WO2005001132A3 Gene expression profiles that identify genetically elite ungulate mammals |
| 05/12/2005 | WO2004113556A8 Assay and kits for detecting protein binding |
| 05/12/2005 | WO2004111606A3 Automated microbiological testing apparatus and method |
| 05/12/2005 | WO2004106887A3 Quality assurance/quality control for high throughput bioassay process |
| 05/12/2005 | WO2004106497A3 Imageable animal model of sars infection |
| 05/12/2005 | WO2004104172A3 Hybridization-mediated analysis of polymorphisms |
| 05/12/2005 | WO2004102149A3 Methods and compositions for the detection of bacterial species |
| 05/12/2005 | WO2004098386A3 Oligonucleotides comprising a molecular switch |
| 05/12/2005 | WO2004097029A3 Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification |
| 05/12/2005 | WO2004092324A3 Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores |
| 05/12/2005 | WO2004090164A3 Method for determining soil condition |
| 05/12/2005 | WO2004083403A3 Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof |
| 05/12/2005 | WO2004081183A3 In vitro dna immortalization and whole genome amplification using libraries generated from randomly fragmented dna |
| 05/12/2005 | WO2004068115A3 Assay method for group transfer reactions |
| 05/12/2005 | WO2004064710A3 Applications of substances binding to gstm for the diagnosis and treatment of cystic carcinomas |
| 05/12/2005 | WO2004050835A3 Predicting animal performance |
| 05/12/2005 | WO2004044137A3 Modified oligomeric compounds and compositions for use in gene modulation |
| 05/12/2005 | WO2004040014A9 Gene expression in biological conditions |
| 05/12/2005 | WO2004029284A3 Efficient generation of stable expression cell lines through the use of scorable homeostatic reporter genes |
| 05/12/2005 | WO2004029281A3 Methods and compositions for rnai mediated inhibition of viral gene expression in mammals |
| 05/12/2005 | WO2004022775A8 Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use |
| 05/12/2005 | WO2004018642A3 Methods for detecting genes associated with bone properties and/or height |
| 05/12/2005 | WO2004009807A8 Two-phase alcohol dehydrogenase-based coupled enzymatic reaction system |
| 05/12/2005 | WO2003091695A3 Identification of biomarkers for detecting prostate cancer |
| 05/12/2005 | WO2003085124A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 05/12/2005 | WO2001079525A3 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 05/12/2005 | US20050102713 Expression vector comprising regulatory sequences associated with expression of antifungal protein for use as tool in generating transgenic plants with enhanced exogeneous gene transcription and insect and herbicide resistance |
| 05/12/2005 | US20050102712 Using chlorophyll biosynthesis enzyme as tool for identifying agents which enhance photosynthetic activity of plants |
| 05/12/2005 | US20050102106 Diagnostic method for assessing a condition of a performance animal |
| 05/12/2005 | US20050101773 Genes required for viability and/or reproduction in c. elegans and their use in the development of anti-nematode agents |
| 05/12/2005 | US20050101771 Used in clinical examinations and can precisely assay glycated proteins |
| 05/12/2005 | US20050101769 CD40-interacting and TRAF-interacting proteins |
| 05/12/2005 | US20050101619 Viricide found from high-throughput cell-free assay that rapidly screen libraries of compounds for viral-capsid binding activity; 1,4-dimercapto-2-butene S,S'-substituted with a benzothiazole, a pyrimidine, or a imidazole ring; NOTE claims are only for a Markush compound; no screening process is claimed |
| 05/12/2005 | US20050101557 Immunostimulatory nucleic acid molecules |
| 05/12/2005 | US20050101556 Genetic engineering; Alzheimer's disease; anticancer agents |
| 05/12/2005 | US20050101554 Methods for treating and preventing infectious disease |
| 05/12/2005 | US20050101536 Modulation of angiogenesis |
| 05/12/2005 | US20050101530 Cellular virus receptors and methods of use |
| 05/12/2005 | US20050101529 Protein modification and maintenance molecules |
| 05/12/2005 | US20050101485 Methods for the identification of inhibitors of biotin synthase expression or activity in plants |
| 05/12/2005 | US20050101019 Method and device for targeted delivery of materials to selected single cells |
| 05/12/2005 | US20050101014 Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
| 05/12/2005 | US20050101004 Screening for a compound to inhibit the urge for urinary incontinence by detecting activation of KCNQ protein in the host cell; measuring the membrane potential of the host cell and selecting the compound whose presence causes hyperpolarization in themembrane potential of the host cell |
| 05/12/2005 | US20050100985 Saturation mutagenesis in directed evolution |
| 05/12/2005 | US20050100980 Using statistical analysis and absortion specta as tools identification of microorganisms |
| 05/12/2005 | US20050100979 Using non-selenium glutathione peroxidase protein concentrations as diagnostic/prognostic tool in detection of neurodegenerative disorders |
| 05/12/2005 | US20050100978 Nitropyrimidine derivative for detection and evaluation of kinase inhibitors |
| 05/12/2005 | US20050100977 Biochemical sensing device |
| 05/12/2005 | US20050100973 Using synaptosomal associated protein-25 (SNAP-25) as tool to screen for clostridial toxin protease activity; food safety; detecting food poisoning |
| 05/12/2005 | US20050100972 Use of grf1 protein for screening molecules |